TEAEs
| Adverse event (>10%) . | Grade 1 or 2 . | Grade 3 . | Grade 4 . | Grade 5 . |
|---|---|---|---|---|
| Fatigue | 79 | 6 | 0 | 0 |
| Nausea | 37 | 1 | 0 | 0 |
| Injection site reaction | 29 | 0 | 0 | 0 |
| Constipation | 23 | 0 | 0 | 0 |
| Dyspnea | 22 | 4 | 0 | 0 |
| Cardiac arrest | 0 | 0 | 0 | 3 |
| Mucositis oral | 22 | 3 | 0 | 0 |
| Diarrhea | 14 | 0 | 0 | 0 |
| Vomiting | 12 | 1 | 0 | 0 |
| Febrile neutropenia | 0 | 32 | 0 | 0 |
| Lung infection | 0 | 25 | 1 | 2 |
| Platelet count decreased | 0 | 16 | 7 | 0 |
| Adverse event (>10%) . | Grade 1 or 2 . | Grade 3 . | Grade 4 . | Grade 5 . |
|---|---|---|---|---|
| Fatigue | 79 | 6 | 0 | 0 |
| Nausea | 37 | 1 | 0 | 0 |
| Injection site reaction | 29 | 0 | 0 | 0 |
| Constipation | 23 | 0 | 0 | 0 |
| Dyspnea | 22 | 4 | 0 | 0 |
| Cardiac arrest | 0 | 0 | 0 | 3 |
| Mucositis oral | 22 | 3 | 0 | 0 |
| Diarrhea | 14 | 0 | 0 | 0 |
| Vomiting | 12 | 1 | 0 | 0 |
| Febrile neutropenia | 0 | 32 | 0 | 0 |
| Lung infection | 0 | 25 | 1 | 2 |
| Platelet count decreased | 0 | 16 | 7 | 0 |